SQI Diagnostics Wins Additional Business from UK-based Customer
PR Newswire - Mon Dec 15, 9:32AM CST
Technology Transfer Agreement Signals Revenue Growth Opportunities
SQD.VN: 0.330 (+0.010)
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2014 Results
PR Newswire - Wed Dec 10, 4:00PM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
SQD.VN: 0.330 (+0.010)
S&P Capital IQ Initiates Coverage on SQI Diagnostics Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Dec 09, 5:10PM CST
S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on SQI Diagnostics Inc.
MHFI: 86.56 (-1.43), SQD.VN: 0.330 (+0.010)
SQI DIAGNOSTICS Advances Commercial Opportunity with Leading Global Pharmaceutical Customer
PR Newswire - Mon Nov 24, 7:00AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
SQD.VN: 0.330 (+0.010)
SQI DIAGNOSTICS Receives FDA Clearance for its Ig_plex Celiac DGP Panel for Sale in the United States
PR Newswire - Thu Nov 13, 2:52PM CST
SQI Diagnostics Inc. (the "Company" or "SQI Diagnostics"
SQD.VN: 0.330 (+0.010)
SQI Diagnostics to Present at the 15th Annual Immunogenicity for Biotherapeutics Conference
PR Newswire - Thu Nov 13, 2:13PM CST
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it will present at the Immunogenicity for Biotherapeutics Conference on Tuesday, October 21, 2014 in Boston, Massachusetts.
SQD.VN: 0.330 (+0.010)
IIROC Trade Resumption - SQI Diagnostics Inc.
Newsfile Corp - Mon Nov 10, 7:19AM CST
Trading resumes in:
IIROC Trade Halt - SQI Diagnostics Inc.
Newsfile Corp - Fri Nov 07, 2:23PM CST
The following issues have been halted by IIROC:
SQI Diagnostics Announces New Chairman of Board of Directors
PR Newswire - Mon Sep 29, 8:05AM CDT
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, is pleased to announce the appointment of Peter Winkley to Chairman of the Board of Directors of SQI, replacing Claude Ricks. Mr. Ricks will continue to serve as a Director on the Board and will continue to provide leadership to the Company.
SQD.VN: 0.330 (+0.010)
SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States
CNW Group - Wed Sep 17, 8:05AM CDT
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that its common shares have been approved for trading in the United States on the OTCQX marketplace ("OTCQX"
SQD.VN: 0.330 (+0.010)
OTC Markets Group Welcomes SQI Diagnostics to OTCQX®
PR Newswire - Wed Sep 17, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company, has qualified to trade on OTCQX®, the best marketplace.
SQD.VN: 0.330 (+0.010)